Follow us on Twitter
Below you will find current and archived press releases for your associated company. Navigate by selecting the year in the list below and click on the press release you want to read. Distribution takes place with a maximum of five minutes delay from press release.
Stockholm, July 26, 2022 - Intervacc AB (publ) (First North: IVACC) ("Intervacc") announces today that the CEO, Andreas Andersson, together with t...
Stockholm, July 20th 2022 - Intervacc AB (publ) announces today that the company has received an order for the equivalent of approximately SEK 3 m...
Stockholm, July 20th, 2022 - Intervacc AB (publ) announces today that the first batch of Strangvac for sale in the UK has been released.
"The...
Intervacc AB (publ) has held its Annual General Meeting ("AGM") on Tuesday 14 June 2022, at which the following resolutions were made.
Adopti...
Stockholm, May 31, 2022 - Intervacc announces today that Strangvac, a vaccine against the highly contagious infectious disease equine strangles, h...
The period in summary
First quarter January 1 - March 31, 2022
- On March 23 the first batch of Strangvac was released for sale in Swed...
Stockholm, May 19, 2022 - Intervacc AB (publ) announces the initiation of a proof-of-concept study to measure the effectiveness of a vaccine to pr...
The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the "Company"), are hereby invited to the Annual General Meeting ("AGM") to be held...
In Norway it has not been allowed previously to vaccinate horses against strangles (infection caused by the bacterium Streptococcus equi). However...
I Norge har det fram till nyligen inte varit tillåtet att vaccinera hästar mot kvarka (infektion orsakad av bakterien Streptococcus equi). Mattils...
Den 23:e mars frisläpptes Strangvac till försäljning i Sverige och veckan efter började de första apoteken att lägga order och få vaccinet leverer...
Stockholm, April 25, 2022 - Intervacc AB (publ) announces positive results from a proof-of-concept study where piglets from vaccinated sows were p...
Stockholm, April 6, 2022 - Intervacc AB (publ) announces that the company's 2021 Annual Report has been published today. The annual report (in Swe...
Stockholm, March 23, 2022 - Intervacc announces today that the first batch of Strangvac, a vaccine against equine Strangles, has been released for...
Stockholm, March 9, 2022 - The European Medicines Agency has today, after reviewing stability data, approved the extension of the shelf life of th...
The period in summary
January 1 - December 31, 2021
- The European Commission granted in August a Marketing Authorisation for Strangvac...
Stockholm, February 16, 2022 - Intervacc AB (publ) announces that the Company's application for a Permit for Sale and Distribution of Strangvac in...
Stockholm, February 1, 2022 - The European patent for Strangvac, a vaccine against equine strangles, is approved and in force until May 2031. Pend...
Stockholm, January 21, 2022 - In the largest study of its kind, published in the 'Equine Veterinary Journal', scientists confirm that the antigens...
